Literature DB >> 1404638

Selective sacral rhizotomy in the management of the reflex neuropathic bladder: a report on 17 patients with long-term followup.

M E Gasparini1, R A Schmidt, E A Tanagho.   

Abstract

During the last 6 years 24 patients with cervical or thoracic spinal cord injuries and a severe reflex neuropathic bladder underwent selective dorsal sacral rhizotomy with the aid of intraoperative neurostimulation and urodynamic monitoring. Preoperative and postoperative evaluation was available in 17 patients. Followup ranged from 2 months to 5 years (mean 32 months). Mean bladder capacity increased significantly after rhizotomy (from 148 +/- 28.1 to 377 +/- 52.9 ml., p less than 0.001), as did mean volume to first contraction (from 99 +/- 28.6 to 270 +/- 39.3 ml., p less than 0.001). No significant changes in bowel or erectile function were noted. Continence was improved in 94%, with 14 patients remaining completely dry and voiding with electrical stimulation or intermittent self-catheterization. The long-term results of selective sacral rhizotomy compare favorably to more aggressive alternatives, such as augmentation cystoplasty or urinary diversion.

Entities:  

Mesh:

Year:  1992        PMID: 1404638     DOI: 10.1016/s0022-5347(17)36862-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  The feasibility study of extradural nerve anastomosis technique for canine bladder reinnervation after spinal cord injury.

Authors:  Jian Tang; Jun Ma; Lei Yang; Xinpeng Huang; Yingbin Ge; Tao Sui; Zhongqing Wei; Xiaojian Cao
Journal:  J Spinal Cord Med       Date:  2016-11       Impact factor: 1.985

2.  Anatomical feasibility of anastomosing intercostal nerves (D10&D11) and subcostal nerve (D12) to S2 ventral root and lumbar plexus for management of bladder function after spinal cord injury.

Authors:  Pawan Agarwal; Vijay Parihar; Rajeev R Kukrele; Ambuj Kumar; Dhananjaya Sharma
Journal:  J Clin Orthop Trauma       Date:  2020-01-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.